Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Traditional nanoparticles (~100nm) have limited efficacy in treating tumor metastasis due to poor lymph node targeting.
• Achieving both efficient penetration and long-term retention with fixed-size nanoparticles remains a challenge in cancer therapy.

Purpose of the Study:

• To develop transformable nanoparticles for enhanced targeting of primary tumors and lymph node metastasis.
• To improve drug retention and anti-tumor efficacy by utilizing click chemistry for nanoparticle aggregation.

Main Methods:

• Engineered "transformable" micelles (~25nm) modified with azide/alkyne groups for click chemical reactions.
• Investigated nanoparticle extravasation, lymph node targeting, and aggregation in 4T1 cells in vitro and in vivo.
• Evaluated anti-tumor efficacy and cytotoxicity of the developed drug delivery system.

Main Results:

• Small micelles (~25nm) effectively targeted lymph nodes, reducing tumor lymph node metastasis by 66.7%.
• Click chemistry-induced aggregation in primary tumors enhanced nanoparticle retention and reduced backflow.
• Demonstrated improved cytotoxicity against 4T1 cells and significant tumor suppression (76.23% with S-PTX (+)).

Conclusions:

• The developed transformable nanoparticle system effectively treats primary tumors and lymphatic metastasis.
• Size-tunable nanoparticles offer a promising strategy for overcoming limitations in current cancer nanomedicine.
• This approach enhances drug delivery, retention, and overall anti-tumor therapeutic outcomes.